On the recordApril 23, 2020
I thank the gentleman for yielding. Madam Speaker, I rise in support of this resolution. It is sad to say, but this coronavirus pandemic has caused some of the greatest suffering in our time for individuals and for our country at large. And yet there are those few who would see this as an opportunity to benefit for themselves and their companies by price gouging or, one might say, pandemic profiteering. We have good reason to be skeptical about many of these companies, including the pharmaceutical industry. For example, even during this crisis, we saw Gilead seek and receive from the FDA 7 years of orphan drug exclusivity for a possible treatment for the virus. Only after organizations stepped in and protested did Gilead go back to the FDA to withdraw their request. Do we really need an oversight committee? Look what has happened already. The SPEAKER pro tempore. The time of the gentlewoman has expired. Mr. McGOVERN. Madam Speaker, I yield an additional 15 seconds to the gentlewoman from Illinois (Ms. Schakowsky).
Source
govinfo.gov




